On April 1, 2021, Liu, Xiangyong; Qiu, Changyong; Sheng, Haitong; Liu, Mengqiang; Shen, Qichao; Du, Guolong; Song, Xiaodong; Ding, Lieming; Wang, Jiabing published a patent.Related Products of 596114-50-0 The title of the patent was Egfr inhibitor, composition and preparation method therefor. And the patent contained the following:
A compound of formula I, a method for using these compounds as an EGFR inhibitor, and a pharmaceutical composition comprising these compounds The compound was used in the treatment, prevention or amelioration of diseases or conditions such as cancer or infection. The experimental process involved the reaction of 2-Chloro-5-isopropylpyrimidine(cas: 596114-50-0).Related Products of 596114-50-0
The Article related to heterocyclic phosphine oxide preparation egfr inhibitor, antitumor activity heterocyclic phosphine oxide, Organometallic and Organometalloidal Compounds: Phosphorus Compounds and other aspects.Related Products of 596114-50-0
Referemce:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia